CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating Activities
Net (loss) income	$ (8,184)	$ 4,986
Adjustments to reconcile net (loss) income to net cash from operating activities:
Depreciation and amortization	12,407	12,964
Amortization of debt issuance costs and Royalty Rights	215	248
Accretion of interest income from short-term investments	(338)	0
Recurring fair value measurements of assets and liabilities	15	9,408
Debt-related expenses	0	9,918
Provisions for inventory and other assets	3,877	1,390
Stock-based compensation	2,615	4,651
Deferred income taxes	0	(1,385)
Changes in assets and liabilities:
Accounts receivable	7,750	3,749
Inventories	(5,271)	(6,511)
Prepaid and other assets	3,150	4,289
Accounts payable and other accrued liabilities	(1,627)	4,906
Accrued rebates, returns and discounts	286	(6,569)
Interest payable	0	(726)
Net cash provided by operating activities	14,895	41,318
Investing Activities
Purchases of property and equipment	0	(528)
Purchase of Sympazan	0	(280)
Purchases of short-term investments	(43,320)	0
Net cash used in investing activities	(43,320)	(808)
Financing Activities
Payments in connection with 2027 Convertible Notes	0	(10,500)
Payment of direct transaction costs related to convertible debt inducement	0	(1,119)
Payment of contingent consideration	0	(15,408)
Payment of Royalty Rights	0	(459)
Proceeds from exercise of stock options	0	157
Payments related to the vesting and settlement of equity awards, net	(281)	(7,947)
Net cash used in financing activities	(281)	(35,276)
Net (decrease) increase in cash and cash equivalents	(28,706)	5,234
Cash and cash equivalents at beginning of year	73,441	64,941
Cash and cash equivalents at end of period	44,735	70,175
Supplemental Disclosure of Cash Flow Information
Net cash paid for income taxes	1,384	2,295
Cash paid for interest	$ 1,300	$ 2,351